From the Guidelines
The recommended antibiotics for bacterial meningitis typically include a combination of vancomycin plus a third-generation cephalosporin such as ceftriaxone or cefotaxime as empiric therapy. For adults, vancomycin is dosed at 15-20 mg/kg IV every 8-12 hours, while ceftriaxone is given at 2g IV every 12 hours. Cefotaxime can be used at 2g IV every 4-6 hours. This combination provides coverage against the most common causative organisms: Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.
Key Considerations
- Treatment should be initiated immediately after obtaining blood cultures and cerebrospinal fluid, without waiting for results, as delays increase mortality 1.
- For patients with penicillin allergies, meropenem (2g IV every 8 hours) may be substituted.
- Once the pathogen is identified, therapy can be narrowed.
- Treatment duration is typically 7-14 days depending on the causative organism, with longer courses for Listeria (ampicillin 2g IV every 4 hours for 21 days) and gram-negative bacilli 1.
- Dexamethasone (0.15 mg/kg IV every 6 hours for 2-4 days) should be considered, especially for pneumococcal meningitis, as it reduces inflammation and improves outcomes when given before or with the first antibiotic dose 1.
Patient Groups and Treatment
- Neonates <1 month old: Amoxicillin/ampicillin/penicillin plus cefotaxime, or amoxicillin/ampicillin plus an aminoglycoside 1.
- Age 1 month to 18 years: Cefotaxime or ceftriaxone plus vancomycin or rifampicin 1.
- Age >18 and <50 years: Cefotaxime or ceftriaxone plus vancomycin or rifampicin 1.
- Age >50 years, or Age >18 and <50 years plus risk factors for Listeria monocytogenes: Cefotaxime or ceftriaxone plus vancomycin or rifampicin plus amoxicillin/ampicillin/penicillin G 1.
From the FDA Drug Label
MENINGITIS Caused by Haemophilus influenzae, Neisseria meningitidis or Streptococcus pneumoniae Bacterial Meningitis caused by E. coli, Group B Streptococci, and other Gram-negative bacteria (Listeria monocytogenes, N. meningitidis)
The recommended antibiotics for treating bacterial meningitis are:
- Ceftriaxone for infections caused by Haemophilus influenzae, Neisseria meningitidis, or Streptococcus pneumoniae 2
- Ampicillin for infections caused by E. coli, Group B Streptococci, and other Gram-negative bacteria (Listeria monocytogenes, N. meningitidis) 3
From the Research
Recommended Antibiotics for Bacterial Meningitis
The following antibiotics are recommended for treating bacterial meningitis:
- Ceftriaxone or cefotaxime as empirical treatment, due to their effectiveness against common causative bacteria such as Streptococcus pneumoniae, Neisseria meningitis, and Haemophilus influenzae 4
- Meropenem as an alternative for penicillin- and cephalosporin-resistant pneumococcal meningitis, although more clinical data are required to confirm its effectiveness 5
- Vancomycin in combination with ceftriaxone or rifampicin for highly cephalosporin-resistant Streptococcus pneumoniae strains 6
- Aminopenicillin and aminoglycoside for Listeria monocytogenes, which remains fully susceptible to aminopenicillin 4
Treatment Considerations
When selecting antibiotics for bacterial meningitis, consider the following:
- The suspected causative bacterium and its antimicrobial susceptibility pattern 4
- The need for rapid CSF sterilization to reduce mortality and morbidity 4
- The potential for antibiotic resistance, allergy, or contraindications, which may require the use of alternative antibiotics or combinations 4
- The importance of achieving high bactericidal titers in the cerebrospinal fluid, as seen with ceftriaxone 7
Specific Antibiotic Regimens
Some studies have investigated specific antibiotic regimens for bacterial meningitis, including:
- Ceftriaxone alone or in combination with vancomycin or rifampicin for pneumococcal meningitis 6
- Ceftriaxone as a single daily dose for the treatment of bacterial meningitis, with CSF concentrations remaining above the MIC of the pathogenic bacteria for an extended period 8
- Ceftriaxone or cefotaxime in combination with ampicillin for suspected bacterial meningitis in adults, to cover Listeria monocytogenes until CSF culture results are available 7